Eventide Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-372,665
| Closed | -$11.4M | – | 169 |
|
|
2023
Q4 | $11.4M | Hold |
372,665
| – | – | 0.19% | 116 |
|
|
2023
Q3 | $11.8M | Sell |
372,665
-120,557
| -24% | -$3.81M | 0.21% | 115 |
|
|
2023
Q2 | $20.1M | Hold |
493,222
| – | – | 0.34% | 84 |
|
|
2023
Q1 | $18.4M | Buy |
493,222
+174,222
| +55% | +$6.49M | 0.34% | 89 |
|
|
2022
Q4 | $11.1M | Hold |
319,000
| – | – | 0.22% | 102 |
|
|
2022
Q3 | $17.9M | Buy |
+319,000
| New | +$17.9M | 0.35% | 79 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 171 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 160 |
|